Loading…
Paushak (PAUSHAKLTD)₹612.45−0.35%Specialty Chemicals
In the Jun 2026 quarter (standalone), Paushak reported sales of ₹83.92 Cr, up 50.0% from Jun 2025, and net profit of ₹15.04 Cr, up 25.0% year on year. For the year to Mar 2026, sales were ₹219 Cr and net profit ₹39.11 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.95 | 51.95 | 53.93 | 51.94 | 56.96 | 48.94 | 51.97 | 55.94 | 58.92 | 48.95 | 54.94 | 83.92 |
| Expenses | 37.93 | 32.92 | 34.91 | 39.94 | 39.95 | 34.92 | 35.91 | 37.94 | 43.90 | 36.90 | 37.92 | 57.86 |
| Operating Profit | 14.02 | 19.02 | 19.01 | 12.02 | 17.02 | 15.02 | 16.02 | 18.02 | 15.03 | 11.01 | 17.01 | 26.02 |
| OPM % | 28.1% | 36.1% | 35.1% | 23.1% | 30.1% | 30.1% | 30.1% | 32.1% | 25.1% | 23.1% | 30.1% | 31.1% |
| Other Income | 7.01 | 3.01 | 7.01 | 4.01 | 4.01 | 6.01 | 0.00 | 2.01 | 1.01 | 1.01 | 8.01 | 3.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 |
| Depreciation | 2.99 | 2.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 4.98 | 7.98 | 7.98 |
| Profit before tax | 17.95 | 17.93 | 22.91 | 11.95 | 16.95 | 16.95 | 11.95 | 15.93 | 10.96 | 6.98 | 15.96 | 18.94 |
| Tax % | 25.1% | 26.1% | 19.1% | 17.0% | 16.1% | 11.1% | 21.1% | 23.1% | 24.1% | 17.1% | 22.1% | 21.1% |
| Net Profit | 13.05 | 14.04 | 18.07 | 10.04 | 14.04 | 15.05 | 10.03 | 12.03 | 9.03 | 6.02 | 13.04 | 15.04 |
| EPS (Rs) | 5.41 | 5.53 | 7.41 | 4.18 | 5.76 | 6.19 | 3.89 | 4.88 | 3.49 | 2.49 | 5.06 | 6.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 77.96 | 71.97 | 105 | 140 | 138 | 141 | 150 | 212 | 206 | 211 | 219 | 247 |
| Expenses | 60.91 | 59.87 | 74.88 | 98.86 | 94.85 | 90.76 | 95.81 | 137 | 142 | 151 | 158 | 177 |
| Operating Profit | 17.02 | 12.02 | 29.02 | 40.06 | 43.08 | 50.08 | 54.05 | 75.13 | 65.04 | 60.09 | 61.04 | 69.07 |
| OPM % | 22.1% | 17.1% | 28.1% | 29.1% | 31.1% | 36.1% | 36.1% | 35.1% | 31.1% | 28.1% | 28.1% | 28.0% |
| Other Income | 3.01 | 5.01 | 3.01 | 13.03 | 7.01 | 6.01 | 5.01 | 11.02 | 20.03 | 14.03 | 12.02 | 13.04 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 1.98 |
| Depreciation | 2.99 | 2.99 | 2.99 | 3.99 | 3.99 | 4.98 | 8.97 | 12.96 | 13.95 | 14.95 | 20.94 | 24.93 |
| Profit before tax | 16.94 | 13.96 | 28.90 | 48.85 | 44.84 | 51.87 | 49.83 | 71.81 | 70.73 | 58.76 | 49.87 | 52.84 |
| Tax % | 25.1% | 22.1% | 26.1% | 20.1% | 23.1% | 28.1% | 25.1% | 25.1% | 23.1% | 16.1% | 22.1% | — |
| Exceptional items | 0.81 | 4.65 | 0.31 | 8.18 | 2.73 | 1.49 | 1.12 | 3.66 | 6.21 | 6.71 | 5.94 | — |
| Net Profit | 12.04 | 11.03 | 21.06 | 39.14 | 35.12 | 37.11 | 38.11 | 54.14 | 54.20 | 49.13 | 39.11 | 43.13 |
| EPS (Rs) | 4.84 | 4.26 | 8.38 | 15.83 | 14.17 | 15.14 | 15.28 | 21.92 | 22.05 | 20.03 | 15.93 | 17.15 |
| Dividend payout % | 7.9% | 9.0% | 4.0% | 4.0% | 5.0% | 5.0% | 10.0% | 10.0% | 11.0% | 12.0% | 15.9% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 3.00 | 3.00 | 2.99 | 12.00 |
| Reserves | 54.01 | 65.01 | 80.04 | 110 | 174 | 224 | 269 | 302 | 351 | 405 | 462 | 479 |
| Borrowings | 0.00 | 0.99 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.96 | 76.96 |
| Other Liabilities | 11.06 | 13.05 | 11.06 | 31.15 | 36.17 | 43.20 | 57.15 | 61.29 | 61.29 | 73.35 | 80.85 | 92.44 |
| Total Liabilities | 69.06 | 82.04 | 94.09 | 144 | 214 | 270 | 329 | 367 | 415 | 482 | 572 | 661 |
| Fixed Assets | 18.03 | 20.05 | 35.09 | 37.10 | 38.12 | 41.07 | 51.09 | 147 | 149 | 152 | 141 | 378 |
| CWIP | 0.99 | 11.96 | 0.00 | 0.99 | 5.98 | 15.97 | 67.77 | 7.97 | 6.98 | 28.93 | 189 | 25.92 |
| Investments | 19.02 | 18.01 | 32.99 | 53.06 | 116 | 163 | 154 | 151 | 182 | 223 | 139 | 150 |
| Other Assets | 30.02 | 31.02 | 26.01 | 53.96 | 53.99 | 49.98 | 56.02 | 61.01 | 78.05 | 76.94 | 102 | 107 |
| Inventories | 7.02 | 9.02 | 9.01 | 12.03 | 18.02 | 16.03 | 14.02 | 19.05 | 23.03 | 22.05 | 22.02 | 37.04 |
| Trade receivables | 22.01 | 21.02 | 16.01 | 39.02 | 32.02 | 26.02 | 33.03 | 40.05 | 52.01 | 51.06 | 55.05 | 55.01 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 |
| Total Assets | 69.06 | 82.04 | 94.09 | 144 | 214 | 270 | 329 | 367 | 415 | 482 | 572 | 661 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 9.01 | 14.01 | 12.02 | 10.01 | 24.01 | 41.01 | 30.03 | 43.99 | 43.02 | 56.01 | 37.99 | 54.02 |
| Cash from investing activity | −7.99 | −12.99 | −11.01 | −9.99 | 0.00 | −39.02 | −29.01 | −42.05 | −38.02 | −50.07 | −57.03 | −94.98 |
| Cash from financing activity | −0.99 | −0.99 | −1.99 | −0.99 | −22.97 | −1.99 | −1.99 | −1.99 | −3.99 | −4.99 | 18.99 | 41.95 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 |
| Capex | 7.99 | 16.97 | 5.99 | 5.99 | 9.99 | 16.97 | 55.94 | 47.96 | 16.97 | 38.94 | 160 | 87.89 |
| Free cash flow | 0.00 | −2.99 | 6.97 | 4.98 | 12.95 | 26.90 | −25.90 | −3.98 | 27.89 | 16.93 | −122 | −33.87 |
| CFO / OP % | 77.0% | 104.0% | 118.0% | 56.0% | 85.0% | 116.0% | 85.1% | 98.0% | 73.0% | 107.0% | 82.0% | 97.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 115 | 98 | 84 | 136 | 86 | 70 | 86 | 98 | 91 | 91 | 95 | 93 |
| Inventory days | 95 | 116 | 124 | 117 | 121 | 130 | 147 | 232 | 179 | 176 | 178 | 291 |
| Days payable | 94 | 104 | 70 | 170 | 73 | 110 | 118 | 227 | 122 | 130 | 167 | 245 |
| Cash conversion cycle | 116 | 110 | 138 | 83 | 133 | 89 | 115 | 103 | 149 | 137 | 107 | 139 |
| Working capital days | 109 | 93 | 93 | 108 | 101 | 76 | 61 | 82 | 94 | 85 | 81 | 65 |
| ROCE % | 32.0% | 25.0% | 12.0% | 29.0% | 27.0% | 21.1% | 20.1% | 17.0% | 21.0% | 17.0% | 11.0% | 8.0% |
For the Jun 2026 quarter, Paushak reported sales of ₹83.92 Cr, up 50.0% year on year and net profit of ₹15.04 Cr, up 25.0% year on year. The operating margin was 31.1%.
Paushak's sales for the year to Mar 2026 were ₹219 Cr; over the last twelve months they were ₹247 Cr.
Net profit for the year to Mar 2026 was ₹39.11 Cr, and ₹43.13 Cr over the last twelve months. Earnings per share over the same trailing period were ₹17.15.
Paushak reported borrowings of ₹76.96 Cr at Mar 2026, against cash and equivalents of ₹0.99 Cr.
Cash from operations was ₹54.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹33.87 Cr.